GGAL vs. BSX
GGAL (Grupo Financiero Galicia S.A.) and BSX (Boston Scientific Corporation) are both stocks. GGAL operates in Banks - Regional (Financial Services), while BSX operates in Medical Devices (Healthcare). Over the past 10 years, GGAL returned 8.22%/yr vs 6.23%/yr for BSX. At a 0.18 correlation, their price movements are largely independent.
Performance
GGAL vs. BSX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GGAL achieves a -4.68% return, which is significantly higher than BSX's -54.10% return. Over the past 10 years, GGAL has outperformed BSX with an annualized return of 8.22%, while BSX has yielded a comparatively lower 6.23% annualized return.
GGAL
- 1D
- 0.02%
- 1M
- -11.39%
- 6M
- 0.05%
- YTD
- -4.68%
- 1Y
- 10.99%
- 3Y*
- 48.34%
- 5Y*
- 50.55%
- 10Y*
- 8.22%
- ALL TIME*
- 5.46%
BSX
- 1D
- -0.59%
- 1M
- -3.36%
- 6M
- -50.30%
- YTD
- -54.10%
- 1Y
- -57.77%
- 3Y*
- -6.27%
- 5Y*
- 0.09%
- 10Y*
- 6.23%
- ALL TIME*
- 7.06%
GGAL vs. BSX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GGAL Grupo Financiero Galicia S.A. | -4.68% | -11.36% | 289.05% | 92.28% | 8.05% | 8.88% | -45.53% | -40.38% | -57.85% | 145.24% |
BSX Boston Scientific Corporation | -54.10% | 6.75% | 54.51% | 24.94% | 8.92% | 18.16% | -20.50% | 27.96% | 42.56% | 14.61% |
Correlation
The correlation between GGAL and BSX is -0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.04 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.14 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Jul 25, 2000 | 0.18 |
The correlation between GGAL and BSX shifts across timeframes, from -0.04 (1 year) to 0.20 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
GGAL:
$8.02B
BSX:
$65.06B
GGAL:
ARS 741.16
BSX:
$2.38
GGAL:
99.61
BSX:
18.42
GGAL:
0.91
BSX:
0.41
GGAL:
0.66
BSX:
3.18
GGAL:
0.24
BSX:
2.53
GGAL:
ARS 13.01T
BSX:
$20.62B
GGAL:
ARS 5.27T
BSX:
$14.52B
GGAL:
ARS 306.88B
BSX:
$4.76B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GGAL vs. BSX — Risk / Return Rank
GGAL
BSX
GGAL vs. BSX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Grupo Financiero Galicia S.A. (GGAL) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GGAL | BSX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.76 | ||
| Sortino ratioReturn per unit of downside risk | +3.46 | ||
| Omega ratioGain probability vs. loss probability | 1.11 | 0.64 | +0.47 |
| Calmar ratioReturn relative to maximum drawdown | 0.22 | -0.96 | +1.18 |
| Martin ratioReturn relative to average drawdown | 0.48 | -1.81 | +2.29 |
Loading charts...
Drawdowns
GGAL vs. BSX - Drawdown Comparison
The maximum GGAL drawdown since its inception was -98.98%, which is greater than BSX's maximum drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for GGAL and BSX.
Loading charts...
Drawdown Indicators
| GGAL | BSX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.98% | -89.15% | -9.83% |
Max Drawdown (1Y)Largest decline over 1 year | -50.03% | -60.58% | +10.55% |
Max Drawdown (3Y)Largest decline over 3 years | -62.94% | -60.58% | -2.36% |
Max Drawdown (5Y)Largest decline over 5 years | -62.94% | -60.58% | -2.36% |
Max Drawdown (10Y)Largest decline over 10 years | -91.70% | -60.58% | -31.12% |
Current DrawdownCurrent decline from peak | -27.09% | -59.52% | +32.43% |
Average DrawdownAverage peak-to-trough decline | -57.24% | -38.81% | -18.43% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 23.16% | 31.89% | -8.73% |
Volatility
GGAL vs. BSX - Volatility Comparison
Grupo Financiero Galicia S.A. (GGAL) has a higher volatility of 16.37% compared to Boston Scientific Corporation (BSX) at 9.83%. This indicates that GGAL's price experiences larger fluctuations and is considered to be riskier than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GGAL | BSX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.37% | 9.83% | +6.54% |
Volatility (6M)Calculated over the trailing 6-month period | 38.17% | 33.81% | +4.36% |
Volatility (1Y)Calculated over the trailing 1-year period | 76.03% | 35.90% | +40.13% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 58.84% | 25.99% | +32.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 62.19% | 27.43% | +34.76% |
Dividends
GGAL vs. BSX - Dividend Comparison
GGAL's dividend yield for the trailing twelve months is around 4.24%, while BSX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSX Boston Scientific Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GGAL Grupo Financiero Galicia S.A. | 4.24% | 2.11% | 3.81% | 6.49% | 4.62% | 0.23% | 0.94% | 1.89% | 1.29% | 0.16% | 0.13% | 0.09% |
Financials
GGAL vs. BSX - Financials Comparison
This section allows you to compare key financial metrics between Grupo Financiero Galicia S.A. and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GGAL vs. BSX - Profitability Comparison
GGAL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Grupo Financiero Galicia S.A. reported a gross profit of 1.11T and revenue of 1.99T. Therefore, the gross margin over that period was 56.0%.
BSX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Boston Scientific Corporation reported a gross profit of 3.61B and revenue of 5.20B. Therefore, the gross margin over that period was 69.4%.
GGAL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Grupo Financiero Galicia S.A. reported an operating income of 66.60B and revenue of 1.99T, resulting in an operating margin of 3.4%.
BSX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Boston Scientific Corporation reported an operating income of 1.07B and revenue of 5.20B, resulting in an operating margin of 20.6%.
GGAL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Grupo Financiero Galicia S.A. reported a net income of 65.18B and revenue of 1.99T, resulting in a net margin of 3.3%.
BSX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Boston Scientific Corporation reported a net income of 1.34B and revenue of 5.20B, resulting in a net margin of 25.7%.
Frequently Asked Questions
GGAL and BSX have a correlation of -0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
GGAL has higher volatility (16.37%) compared to BSX (9.83%). In terms of maximum drawdown, GGAL dropped -98.98% vs BSX's -89.15%.
GGAL currently has the higher Sharpe Ratio (0.15 vs -1.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GGAL and BSX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer